Professor Andrew Biankin


Professor Andrew Biankin

AO, B.Med.Sc., M.B.,B.S.(HONS), F.R.A.C.S., F.F.S.(R.C.P.A.), F.R.C.S.(Glasg), F.R.C.S.(Edin), Ph.D., F.R.S.E., F.Med.Sci.

Regius Chair of Surgery, Director, Wolfson Wohl Cancer Research Centre, University of Glasgow

Director, Glasgow Precision Oncology Laboratory
Chairman, Precision-Panc Therapeutic Development Platform
Executive Director, International Cancer Genome Consortium
Specialist in Precision Oncology and Therapeutic Development

Professor Andrew Biankin is the Regius Chair of Surgery at the University of Glasgow, a Cancer Research UK Clinician Scientist, a Wellcome Trust Senior Investigator, a Fellow of the Royal Society of Edinburgh and the Academy of Medical Sciences. He is the Director of the Wolfson Wohl Cancer Research Centre which is focused on precision oncology and established the Glasgow Precision Oncology Laboratory which he directs and has produced the “Glasgow Cancer Test” which is being used world-wide. He plays leadership roles in national and international consortia in cancer genomics and therapeutic development including the Chair of Precision-Panc and Executive Director of the International Cancer Genome Consortium. He has authored over 200 articles in major journals including seminal works on cancer, genomics and precision medicine and works closely with industry to bring discoveries to the clinic.

E-AHPBA Management Office

13 Whittingehame Drive
Glasgow, G12 0XT, United Kingdom
+44 (0) 141 530 2760For S


E-AHPBA website


Contact: Carrie Hooper

E-AHPBA Executive Officer
© Copyright 2020 E-AHPBA. All Rights | Privacy Policy | Cookies Policy


Cookies user prefences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics